06/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

06/2024

Jun 27, 2024, 10:05 | Blog
CancerLinQ - TraiLinQ is revolutionizing the use of data to fill clinical trials
CancerLinQ shared on X: "Day 2 of the 2024 Association of American Cancer Institutes meeting is…
Jun 27, 2024, 09:54 | Blog
About the challenges that survivors face - Childhood Cancer International - Europe
Childhood Cancer International - Europe shared a post on LinkedIn:  “International Childhood Cancer Survivors Week…
Jun 27, 2024, 09:29 | Blog
The LBAs for the ESMOGI24 are now live
ESMO shared on X: "The LBAs for the ESMO Gastrointestinal Cancers Congress 2024 are now live.…
Jun 27, 2024, 09:10 | Insight
The promise of immuno-oncology in the neoadjuvant setting - ESMO
The European Society for Medical Oncology (ESMO) shared on LinkedIn: “The promise of immuno-oncology in…
Jun 27, 2024, 09:01 | Insight
Piotr Wysocki: Anti-inflammatory drugs improve outcomes of patients with early PIK3CA-mutated colorectal cancer
Piotr Wysocki recently posted on LinkedIn: "For many years, anti-inflammatory drugs, mainly aspirin and celecoxib, have…
Jun 27, 2024, 08:56 | Societies
Teresa Macarulla kicks it off at ESMOGI24
Lizzy Smyth, Consultant Medical Oncologist in upper GI oncology at Oxford University, shared on X:…
Jun 27, 2024, 08:45 | Blog
Some papers to read today suggested by Wafik S. El-Deiry
Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, shared…
Jun 27, 2024, 08:37 | Societies
Angela Lamarca: Subgroup analysis on NETTER2
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:…
Jun 27, 2024, 08:31 | Societies
Arndt Vogel: Phase I study of the PKMYT1 inhibitor lunresertib in combination with FOLFIRI
Arndt Vogel shared on X: "Phase I study of the PKMYT1 inhibitor lunresertib in combination…
Jun 27, 2024, 08:26 | Societies
Jia Liu: Great summary of biliary tract cancer and gene target therapy at ESMOGI24
Jia Liu, Translational Researcher at The Kinghorn Cancer Centre, shared on X: "Great summary of…
All: 2742 Posts: 351 - 360
Special Coverage